Literature DB >> 27277019

Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy.

Gaël Dréan1, Oscar Acosta1, Caroline Lafond2, Antoine Simon1, Renaud de Crevoisier2, Pascal Haigron1.   

Abstract

PURPOSE: Recent studies revealed a trend toward voxelwise population analysis in order to understand the local dose/toxicity relationships in prostate cancer radiotherapy. Such approaches require, however, an accurate interindividual mapping of the anatomies and 3D dose distributions toward a common coordinate system. This step is challenging due to the high interindividual variability. In this paper, the authors propose a method designed for interindividual nonrigid registration of the rectum and dose mapping for population analysis.
METHODS: The method is based on the computation of a normalized structural description of the rectum using a Laplacian-based model. This description takes advantage of the tubular structure of the rectum and its centerline to be embedded in a nonrigid registration-based scheme. The performances of the method were evaluated on 30 individuals treated for prostate cancer in a leave-one-out cross validation.
RESULTS: Performance was measured using classical metrics (Dice score and Hausdorff distance), along with new metrics devised to better assess dose mapping in relation with structural deformation (dose-organ overlap). Considering these scores, the proposed method outperforms intensity-based and distance maps-based registration methods.
CONCLUSIONS: The proposed method allows for accurately mapping interindividual 3D dose distributions toward a single anatomical template, opening the way for further voxelwise statistical analysis.

Entities:  

Mesh:

Year:  2016        PMID: 27277019     DOI: 10.1118/1.4948501

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  Anatomy-guided multimodal registration by learning segmentation without ground truth: Application to intraprocedural CBCT/MR liver segmentation and registration.

Authors:  Bo Zhou; Zachary Augenfeld; Julius Chapiro; S Kevin Zhou; Chi Liu; James S Duncan
Journal:  Med Image Anal       Date:  2021-03-21       Impact factor: 13.828

2.  Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.

Authors:  L E A Shelley; J E Scaife; M Romanchikova; K Harrison; J R Forman; A M Bates; D J Noble; R Jena; M A Parker; M P F Sutcliffe; S J Thomas; N G Burnet
Journal:  Radiother Oncol       Date:  2017-04-28       Impact factor: 6.280

3.  Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy.

Authors:  Leila E A Shelley; Michael P F Sutcliffe; Simon J Thomas; David J Noble; Marina Romanchikova; Karl Harrison; Amy M Bates; Neil G Burnet; Raj Jena
Journal:  Phys Imaging Radiat Oncol       Date:  2020-04

4.  A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis.

Authors:  Therese Sjöholm; Simon Ekström; Robin Strand; Håkan Ahlström; Lars Lind; Filip Malmberg; Joel Kullberg
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

5.  Performance evaluation of a newly developed three-dimensional model-based global-to-local registration in prostate cancer.

Authors:  Mitsuhiro Nakamura; Megumi Nakao; Hideaki Hirashima; Hiraku Iramina; Takashi Mizowaki
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

6.  Quantitative assessment of intra- and inter-modality deformable image registration of the heart, left ventricle, and thoracic aorta on longitudinal 4D-CT and MR images.

Authors:  Alireza Omidi; Elisabeth Weiss; John S Wilson; Mihaela Rosu-Bubulac
Journal:  J Appl Clin Med Phys       Date:  2021-12-27       Impact factor: 2.102

7.  Radiation Pneumonitis in Thoracic Cancer Patients: Multi-Center Voxel-Based Analysis.

Authors:  Giuseppe Palma; Serena Monti; Roberto Pacelli; Zhongxing Liao; Joseph O Deasy; Radhe Mohan; Laura Cella
Journal:  Cancers (Basel)       Date:  2021-07-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.